We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01269021
Recruitment Status : Completed
First Posted : January 4, 2011
Last Update Posted : March 17, 2016
Information provided by (Responsible Party):
Zhi-Hong Liu, M.D., Nanjing University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : April 2014